Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TOBI Podhaler User Interface Validation in Cystic Fibrosis
NCT03502070Phase 4Completed
- Sponsor
- Mylan
- Start
- Jun 2018
- Primary completion
- Mar 2019
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial, sponsored by Mylan. Primary endpoint: Number of Participants With Critical Use Errors and Close Calls Associated With the Simulated Inhalation of One Dose Using TOBI Podhaler at 1 Day. Started Jun 2018; status: completed.
Beyond the preview
Go deeper on NCT03502070.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03502070.